hotspot -WSS

hotspot

author：fashion 2025-09-14 18:24:52 - browse：156

Zepbound, a injectable drug on a gradient background of dark purple and green — biotech coverage from STAT — Illustration: STAT; Source: Eli Lilly/AP

A California biotech developing a combination therapy with the obesity drug Zepbound has raised a $170 million Series D round.

The company, BioAge, raised money from more than a dozen investors. Sofinnova Investments led the round, which also included Eli Lilly and Amgen’s venture arms and previous investor Andreessen Horowitz.

BioAge’s primary focus is in developing medications that boost a person’s healthspan, or the number of healthy years a person lives. The company has drugs in development for neuroinflammation and brain aging. But the majority of the Series D proceeds will be used to develop the company’s lead drug candidate azelaprag, which is being tested in combination with Zepbound. That drug program is what grabbed Sofinnova’s attention, according to managing partner Jim Healy, who recently became chairman of BioAge’s board.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： More regulation could be coming for drug ads

Wikipedia

WSS

Lessons Learned: This is why you network to find that industry job you want

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Zapping the brain for stroke rehab: Pivotal clinical trial begins

Does Paxlovid work in people vaccinated against Covid

Wikipedia

hotspot

knowledge

As demand for Covid shots wanes, Moderna seeks its next success

Gene therapy denied for Afghan refugee whose father aided U.S.

The cancer drug shortage isn’t new — and neither are the solutions

Biden praises World Series champion Astros for impact off the field during White House celebration

Anesthesiologist group: stop taking Ozempic before surgery

Medicare Advantage overpayments discussion gets experts fired up

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Medicare Advantage coverage denials need scrutiny, senators say

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Stories you might have missed in 2023: health, science, medicine

leisure time

Arena BioWorks launches in Cambridge to speed drug discovery

Zapping the brain for stroke rehab: Pivotal clinical trial begins

Lessons Learned: This is why you network to find that industry job you want

Lessons Learned: This is why you network to find that industry job you want

Male doctors called my cancer incurable. A female doctor showed it wasn't

FTX founder Sam Bankman

explore

Wikipedia

explore

entertainment